Valuation: Recordati

Market Cap 1.09TCr 1.21TCr 1TCr 906.24Cr 1.69TCr 1,15400Cr 1.72TCr 12TCr 4.77TCr 60TCr 4.55TCr 4.45TCr 1,91300Cr P/E 2026 *
21.6x
P/E 2027 * 17.5x
Enterprise Value 1.26TCr 1.41TCr 1.17TCr 1.05TCr 1.97TCr 1,34300Cr 2TCr 14TCr 5.55TCr 70TCr 5.29TCr 5.18TCr 2,22600Cr EV / Sales 2026 *
4.52x
EV / Sales 2027 * 4.07x
Free-Float
50.46%
Yield 2026 *
2.87%
Yield 2027 * 3.17%
1 day+0.09%
1 week+0.09%
Current month+0.66%
1 month-0.28%
3 months+3.31%
6 months+6.38%
Current year+9.19%
1 week 52.75
Extreme 52.75
53.8
1 month 52.2
Extreme 52.2
53.8
Current year 43.76
Extreme 43.76
53.8
1 year 43.76
Extreme 43.76
54.45
3 years 43.19
Extreme 43.19
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 24.55
Extreme 24.55
60.95
Manager TitleAgeSince
Chief Executive Officer 64 01/12/2021
Director of Finance/CFO 56 01/01/2026
Chief Tech/Sci/R&D Officer 56 01/10/2023
Director TitleAgeSince
Chairman 54 01/12/2021
Chairman 57 12/06/2018
Director/Board Member 53 12/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
11/12/25
Arisca SRL
BuyCompany 10,071 0.0048%
11/12/25 Buy

Chief Financial Officer

2,000 0.0010%
11/12/25 Buy

Chief Financial Officer

2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%+0.09%+4.64%+22.06% 1.21TCr
+6.63%+8.10%+67.50%+145.20% 1,14800Cr
+1.53%+6.76%+47.22%+89.01% 65TCr
+1.68%+2.10%+27.80%+109.31% 51TCr
+0.73%+2.47%+53.85%+68.96% 38TCr
+3.83%-2.37%+68.14%+42.32% 35TCr
+2.38%+4.27%+33.81%+57.95% 29TCr
+2.26%+3.47%+5.21%+28.92% 26TCr
+1.97%+5.11%+57.74%+76.14% 24TCr
+4.03%+7.84%+40.49%+116.14% 20TCr
Average +3.06%+1.25%+40.64%+75.60% 40.49TCr
Weighted average by Cap. +3.74%+1.50%+49.44%+95.75%

Financials

2026 *2027 *
Net sales 279.21Cr 311.72Cr 257.59Cr 233.1Cr 435.88Cr 30TCr 442.92Cr 3.07TCr 1.23TCr 16TCr 1.17TCr 1.14TCr 49TCr 302.79Cr 338.05Cr 279.35Cr 252.79Cr 472.7Cr 32TCr 480.34Cr 3.33TCr 1.33TCr 17TCr 1.27TCr 1.24TCr 53TCr
Net income 57Cr 64Cr 52Cr 47Cr 89Cr 6.05TCr 90Cr 626.16Cr 249.8Cr 3.17TCr 238.36Cr 233.29Cr 10TCr 68Cr 76Cr 63Cr 57Cr 106.8Cr 7.27TCr 108.53Cr 753.01Cr 300.41Cr 3.81TCr 286.65Cr 280.55Cr 12TCr
Net Debt 177.41Cr 198.07Cr 163.67Cr 148.11Cr 276.96Cr 19TCr 281.43Cr 1.95TCr 779Cr 9.87TCr 743.33Cr 727.5Cr 31TCr 146.2Cr 163.22Cr 134.88Cr 122.06Cr 228.24Cr 16TCr 231.93Cr 1.61TCr 641.96Cr 8.13TCr 612.57Cr 599.52Cr 26TCr
Projected Income Statement - Annual - Recordati
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
4,654
Date Price Change Volume
29/26/29 €53.00 +0.09% 16,48,519
28/26/28 €52.95 +0.38% 1,41,771
27/26/27 €52.75 -0.47% 1,23,313
26/26/26 €53.00 -1.49% 2,18,901
23/26/23 €53.80 +1.61% 8,16,855
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Recordati
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
52.95EUR
Average target price
56.72EUR
Spread / Average Target
+7.13%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Recordati